Dr. Morris is an Associate Professor in the Department of Gastrointestinal Medical Oncology at the University of Texas – MD Anderson Cancer Center. After obtaining his M.D. degree at the University of Tennessee Health Sciences Center, he completed his residency in Internal Medicine at Duke University and his fellowship in hematology/oncology at MD Anderson, where he joined the faculty in 2015. His clinical practice focuses on the treatment of gastrointestinal cancers, and he has written multiple clinical trials which incorporate novel therapeutic approaches involving targeted therapies and immunotherapy. His work has been featured in publications in the New England Journal of Medicine, Lancet Oncology, Cancer Discovery, JAMA Oncology, and the Journal of Clinical Oncology.